125 related articles for article (PubMed ID: 20943434)
21. Effect of deep brain stimulation and L-Dopa on electrocortical rhythms related to movement in Parkinson's disease.
Devos D; Defebvre L
Prog Brain Res; 2006; 159():331-49. PubMed ID: 17071241
[TBL] [Abstract][Full Text] [Related]
22. Influence of basal ganglia on upper limb locomotor synergies. Evidence from deep brain stimulation and L-DOPA treatment in Parkinson's disease.
Crenna P; Carpinella I; Lopiano L; Marzegan A; Rabuffetti M; Rizzone M; Lanotte M; Ferrarin M
Brain; 2008 Dec; 131(Pt 12):3410-20. PubMed ID: 18952669
[TBL] [Abstract][Full Text] [Related]
23. Subthalamic nucleus stimulation in Parkinson's disease patients intolerant to levodopa.
Lyons KE; Davis JT; Pahwa R
Stereotact Funct Neurosurg; 2007; 85(4):169-74. PubMed ID: 17259749
[TBL] [Abstract][Full Text] [Related]
24. Deep brain stimulation effects on gait variability in Parkinson's disease.
Hausdorff JM; Gruendlinger L; Scollins L; O'Herron S; Tarsy D
Mov Disord; 2009 Aug; 24(11):1688-92. PubMed ID: 19554569
[TBL] [Abstract][Full Text] [Related]
25. Differential effects of levodopa and subthalamic nucleus deep brain stimulation on bradykinesia in Parkinson's disease.
Timmermann L; Braun M; Groiss S; Wojtecki L; Ostrowski S; Krause H; Pollok B; Südmeyer M; Ploner M; Gross J; Maarouf M; Voges J; Sturm V; Schnitzler A
Mov Disord; 2008 Jan; 23(2):218-27. PubMed ID: 18044706
[TBL] [Abstract][Full Text] [Related]
26. Subthalamic nucleus stimulation does not cause deterioration of preexisting hallucinations in Parkinson's disease patients.
Yoshida F; Miyagi Y; Kishimoto J; Morioka T; Murakami N; Hashiguchi K; Samura K; Sakae N; Yamasaki R; Kawaguchi M; Sasaki T
Stereotact Funct Neurosurg; 2009; 87(1):45-9. PubMed ID: 19174620
[TBL] [Abstract][Full Text] [Related]
27. The beneficial effects of subthalamic nucleus stimulation on manipulative finger force control in Parkinson's disease.
Nowak DA; Topka H; Tisch S; Hariz M; Limousin P; Rothwell JC
Exp Neurol; 2005 Jun; 193(2):427-36. PubMed ID: 15869945
[TBL] [Abstract][Full Text] [Related]
28. Effects of subthalamic nucleus stimulation and L-dopa in trunk kinematics of patients with Parkinson's disease.
Ferrarin M; Rizzone M; Lopiano L; Recalcati M; Pedotti A
Gait Posture; 2004 Apr; 19(2):164-71. PubMed ID: 15013505
[TBL] [Abstract][Full Text] [Related]
29. Movement-related modulation of neural activity in human basal ganglia and its L-DOPA dependency: recordings from deep brain stimulation electrodes in patients with Parkinson's disease.
Priori A; Foffani G; Pesenti A; Bianchi A; Chiesa V; Baselli G; Caputo E; Tamma F; Rampini P; Egidi M; Locatelli M; Barbieri S; Scarlato G
Neurol Sci; 2002 Sep; 23 Suppl 2():S101-2. PubMed ID: 12548363
[TBL] [Abstract][Full Text] [Related]
30. Suicide attempts after subthalamic nucleus stimulation for Parkinson's disease.
Rodrigues AM; Rosas MJ; Gago MF; Sousa C; Fonseca R; Linhares P; Basto MA; Sousa G; Garrett C; Vaz R
Eur Neurol; 2010; 63(3):176-9. PubMed ID: 20197662
[TBL] [Abstract][Full Text] [Related]
31. Involvement of the subthalamic nucleus in impulse control disorders associated with Parkinson's disease.
Rodriguez-Oroz MC; López-Azcárate J; Garcia-Garcia D; Alegre M; Toledo J; Valencia M; Guridi J; Artieda J; Obeso JA
Brain; 2011 Jan; 134(Pt 1):36-49. PubMed ID: 21059746
[TBL] [Abstract][Full Text] [Related]
32. Restless legs syndrome in Parkinson's disease patients may improve with subthalamic stimulation.
Driver-Dunckley E; Evidente VG; Adler CH; Hillman R; Hernandez J; Fletcher G; Lyons MK
Mov Disord; 2006 Aug; 21(8):1287-9. PubMed ID: 16671093
[TBL] [Abstract][Full Text] [Related]
33. Acute psychotropic effects of bilateral subthalamic nucleus stimulation and levodopa in Parkinson's disease.
Funkiewiez A; Ardouin C; Krack P; Fraix V; Van Blercom N; Xie J; Moro E; Benabid AL; Pollak P
Mov Disord; 2003 May; 18(5):524-30. PubMed ID: 12722166
[TBL] [Abstract][Full Text] [Related]
34. Bilateral subthalamic stimulation effects on oral force control in Parkinson's disease.
Pinto S; Gentil M; Fraix V; Benabid AL; Pollak P
J Neurol; 2003 Feb; 250(2):179-87. PubMed ID: 12574948
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of bilateral subthalamic nucleus (STN) stimulation in Parkinson's disease.
Erola T; Heikkinen ER; Haapaniemi T; Tuominen J; Juolasmaa A; Myllylä VV
Acta Neurochir (Wien); 2006 Apr; 148(4):389-94. PubMed ID: 16284705
[TBL] [Abstract][Full Text] [Related]
36. Mechanisms of body weight gain in patients with Parkinson's disease after subthalamic stimulation.
Montaurier C; Morio B; Bannier S; Derost P; Arnaud P; Brandolini-Bunlon M; Giraudet C; Boirie Y; Durif F
Brain; 2007 Jul; 130(Pt 7):1808-18. PubMed ID: 17535833
[TBL] [Abstract][Full Text] [Related]
37. Disturbed intracortical excitability in early Parkinson's disease is l-DOPA dose related: a prospective 12-month paired TMS study.
Bares M; Kanovský P; Rektor I
Parkinsonism Relat Disord; 2007 Dec; 13(8):489-94. PubMed ID: 17449315
[TBL] [Abstract][Full Text] [Related]
38. Subthalamic oscillatory activities at beta or higher frequency do not change after high-frequency DBS in Parkinson's disease.
Foffani G; Ardolino G; Egidi M; Caputo E; Bossi B; Priori A
Brain Res Bull; 2006 Mar; 69(2):123-30. PubMed ID: 16533660
[TBL] [Abstract][Full Text] [Related]
39. Does subthalamic nucleus deep brain stimulation really improve quality of life in Parkinson's disease?
Gronchi-Perrin A; Viollier S; Ghika J; Combremont P; Villemure JG; Bogousslavsky J; Burkhard PR; Vingerhoets F
Mov Disord; 2006 Sep; 21(9):1465-8. PubMed ID: 16763974
[TBL] [Abstract][Full Text] [Related]
40. The effects of levodopa and ongoing deep brain stimulation on subthalamic beta oscillations in Parkinson's disease.
Giannicola G; Marceglia S; Rossi L; Mrakic-Sposta S; Rampini P; Tamma F; Cogiamanian F; Barbieri S; Priori A
Exp Neurol; 2010 Nov; 226(1):120-7. PubMed ID: 20713047
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
